---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-24-000124"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:22:15.427713+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Maravai LifeSciences Chairman Carl Hull Retires; R. Andrew Eckert Appointed Chairman

## Summary
- Founder Carl Hull retires as Executive Chairman and resigns from Board, effective Dec 5, 2024; departure not related to any disagreement.
- R. Andrew Eckert unanimously elected Chairman of the Board, effective Dec 5, 2024; he is a healthcare industry veteran with prior executive roles.
- Eckert receives annual cash retainer of $175,000 (starting Jan 1, 2025) and RSU awards with total grant date fair value of $1.25M, subject to vesting.
- Initial RSU award of $750K vests one-third immediately, remainder at 2025 annual meeting and one year later; second award of $500K expected at 2025 annual meeting.
- Carl Hull founded Maravai in 2014, served as CEO until Oct 2022 when he became Executive Chairman.

## SEC filing metadata
- accession: 0001823239-24-000124
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000124/0001823239-24-000124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000124/mrvi-20241203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-24-000124
- JSON: https://secwatch.observer/filing/0001823239-24-000124.json
- Plain text: https://secwatch.observer/filing/0001823239-24-000124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.